All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| UAM / Universal American Corp.
|
|
|
|
|
|
|
|
| DRRX / DURECT Corporation
|
|
|
|
|
|
|
|
| CYBX / Cyberonics, Inc.
|
|
|
|
|
|
|
|
| ESRX / Express Scripts Holding Co.
|
|
|
|
|
|
|
|
| AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| AZN / AstraZeneca PLC - Depositary Receipt (Common Stock) Call
|
|
|
|
|
|
|
|
| TOYOF / Toyota Motor Corporation
|
|
|
|
|
|
|
|
| DGX / Quest Diagnostics Incorporated
|
|
|
|
|
|
|
|
| NVTA / Invitae Corporation
|
|
|
|
|
|
|
|
| INNOCOLL AG
/ SPONSORED ADR (47580Q103) |
|
|
|
|
|
|
|
| KND / Kindred Healthcare, Inc.
|
|
|
|
|
|
|
|
| KERX / Keryx Biopharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| OFIX / Orthofix Medical Inc.
|
|
|
|
|
|
|
|
| ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| PODD / Insulet Corporation
|
|
|
|
|
|
|
|
| TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| LH / Labcorp Holdings Inc.
|
|
|
|
|
|
|
|
| EPRSQ / Epirus Biopharmaceuticals Inc
|
|
|
|
|
|
|
|
| DXTR / Dextera Surgical Inc.
|
|
|
|
|
|
|
|
| VCYT / Veracyte, Inc.
|
|
|
|
|
|
|
|
| BIOS / BioPlus Acquisition Corp - Class A
|
|
|
|
|
|
|
|
| US3723091043 / GenMark Diagnostics, Inc
|
|
|
|
|
|
|
|
| CCRN / Cross Country Healthcare, Inc.
|
|
|
|
|
|
|
|
| US40425J1016 / HMS Holdings Corp.
|
|
|
|
|
|
|
|
| 74365AAB7 / Protalix BioTherapeutics, Inc. Bonds 4.5% 9/15/18
|
|
|
|
|
|
|
|
| CBIO / Crescent Biopharma, Inc.
|
|
|
|
|
|
|
|
| MJN / Mead Johnson Nutrition Co.
|
|
|
|
|
|
|
|
| GHDX / Genomic Health, Inc.
|
|
|
|
|
|
|
|
| XLV / The Select Sector SPDR Trust - The Health Care Select Sector SPDR Fund Put
|
|
|
|
|
|
|
|
| 87611RAA6 / Targacept Inc Bond
|
|
|
|
|
|
|
|
| UNIS / Unilife Corp
|
|
|
|
|
|
|
|
| MDCO / Medicines Company
|
|
|
|
|
|
|
|
| US00C4U1L353 / Mylan N.V.
|
|
|
|
|
|
|
|
| MASI / Masimo Corporation
|
|
|
|
|
|
|
|
| ANGO / AngioDynamics, Inc.
|
|
|
|
|
|
|
|
| ARNA / Arena Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| ABT / Abbott Laboratories
|
|
|
|
|
|
|
|
| ATXS / Astria Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ARIA / ARIAD Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| JNJ / Johnson & Johnson Call
|
|
|
|
|
|
|
|
| SQNM / Sequenom, Inc.
|
|
|
|
|
|
|
|
| NKTR / Nektar Therapeutics
|
|
|
|
|
|
|
|
| BIOL / BIOLASE, Inc. Call
|
|
|
|
|
|
|
|
| XRAY / DENTSPLY SIRONA Inc.
|
|
|
|
|
|
|
|
| SPY / SPDR S&P 500 ETF Put
|
|
|
|
|
|
|
|
| NUVA / Nuvasive Inc
|
|
|
|
|
|
|
|
| BIOL / BIOLASE, Inc.
|
|
|
|
|
|
|
|
| PLX / Protalix BioTherapeutics, Inc.
|
|
|
|
|
|
|
|
| PRGO / Perrigo Company plc
|
|
|
|
|
|
|
|
| SEM / Select Medical Holdings Corporation
|
|
|
|
|
|
|
|
| OSUR / OraSure Technologies, Inc.
|
|
|
|
|
|
|
|
| CI / The Cigna Group
|
|
|
|
|
|
|
|
